Baxter BioPharma Solutions

Baxter-BioPharma-Solutions.png

Sterile Contract Manufacturing

With over 85 years of parenteral experience, BioPharma Solutions (a business unit of Baxter) offers a variety of contract manufacturing form/fill/finish services and solutions for injectables, designed to meet complex and traditional sterile manufacturing challenges.  In addition, we are the only CMO to offer a manufacturer-prepared, commercial-scale aseptic filling process for premixed drugs in flexible IV bags.

BioPharma Solutions provides our clients with confidence of delivery, service, and integrity - we know the work we do is ultimately vital to the patients you serve.  Areas of expertise include:

  • Sterile Contract Manufacturing Solutions
    • Prefilled Syringe Filling
    • Liquid and Lyophilized Vial Filling
    • Cartridge Filling
    • Diluents for Reconstitution
    • Powder Filled Vials
    • Sterile Crystallization
  • Parenteral Delivery Systems
    • Frozen Premix System
    • Liquid Premix System
  • Drug Categories
    • Small molecules
    • Biologics
    • Vaccines
    • Cytotoxics
    • Antibody-Drug Conjugates (ADCs)
    • Highly potent compounds

The strength of Baxter's global network lies in efficient, quality cGMP manufacturing — enabling BioPharma Solutions to deliver cost-effective results built on best practices and operational excellence.

  • A leader in sterile contract manufacturing, Baxter's facility in Bloomington, Indiana, USA serves client needs from clinical development through commercial launch.
  • A world-class manufacturer of oncology products, Baxter's Halle/Westfalen, Germany facility offers dedicated clinical through commercial production.

Related Resources

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Content provided by Baxter BioPharma Solutions

White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the available options and provides some considerations for developing & manufacturing the product.

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Content provided by Baxter BioPharma Solutions

White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain selection. The timeline for development of a seasonal influenza vaccine...

Best Practices in Formulation and Lyo Development

Best Practices in Formulation and Lyo Development

Content provided by Baxter BioPharma Solutions

White Paper

The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose, in the native secondary and tertiary...